Amber Hoberg, MSN, APRN, PMHNP-BC, discusses how providers can reassess treatment plans should TD develop and what practices can be incorporated to identify the disorder.
Amber Hoberg, MSN, APRN, PMHNP-BC, discusses how providers can reassess treatment plans should TD develop and what practices can be incorporated to identify the disorder.
Andrew Penn, MS, PMHNP, discusses the recent vote by the FDA's advisory committee (PDAC) against an MDMA-based therapy for the treatment of PTSD in adults and sheds light on what this means for the future of PTSD treatment.
Andrew Penn, MS, PMHNP, discusses the recent vote by the FDA's advisory committee (PDAC) against an MDMA-based therapy for the treatment of PTSD in adults and sheds light on what this means for the future of PTSD treatment.
Tani Weiner, the co-chair of the Polsinelli law firm’s Behavioral Health Law Group, discusses factors that are driving behavior health transaction trends, the shift from fee-for-service to value-based care, staffing challenges, and the...
Tani Weiner, the co-chair of the Polsinelli law firm’s Behavioral Health Law Group, discusses factors that are driving behavior health transaction trends, the shift from fee-for-service to value-based care, staffing challenges, and the...
Andrew Tatarsky, PhD, defines the 4 principles of harm reduction and explains why integrative harm reduction psychotherapy can appeal to patients who are resistant to an abstinence-based approach at the outset of recovery.
Andrew Tatarsky, PhD, defines the 4 principles of harm reduction and explains why integrative harm reduction psychotherapy can appeal to patients who are resistant to an abstinence-based approach at the outset of recovery.
